GFI submitted comments in response to the USDA’s Advanced Notice of Proposed Rulemaking (ANPR) regarding cultivated meat labeling. GFI advocates for a clear, practical, and flexible regulatory pathway to market for these products and recommends that USDA-FSIS create a regulatory framework that treats cultivated products and conventional products fairly and equally.
GFI submitted comments to FDA pushing back on the National Milk Producers Federation's proposal to label plant-based dairy products as “imitation” milk.
GFI's comment supports a cautious and flexible approach towards labeling as cultivated seafood comes to market. Learn why we support regulatory flexibility for cultivated seafood.
GFI’s comment supports the regulatory framework described in the Harvard Law School Petition. Learn why we support regulatory flexibility for cultivated meat.
GFI urges FDA to establish principles for modernizing food standards that account for all foods. Learn why doing so is vital to FDA’s goal of supporting innovation.
GFI’s supplement highlights market developments since submitting its Citizen Petition. Learn why the developments demonstrate a need for clarity from FDA.
GFI’s comment encourages FDA to clarify that new foods may be named by reference to the names of other foods. Learn why doing so supports FDA’s goal of promoting innovation.
GFI’s comment explains its concerns with MDAC’s proposed labeling requirements for cultivated meat. Learn why the proposed requirements are unconstitutional.
GFI’s comment discusses the role labels serve on plant-based dairy products. Learn why FDA should not restrict plant-based dairy’s clear labels.
GFI’s comment applauds USDA and FDA’s commitment to working together to ensure the safety of cultivated meat. Learn why we support the joint regulatory framework.
